Evolving Perspectives: USPTO Call for Comments on Patent Eligibility Comes to a Close (Part 1)
IPilogue
NOVEMBER 23, 2021
In Illumina Inc v Ariosa Diagnostics Inc , the District Court rejected patent claims related to methods of isolating fetal DNA from maternal blood plasma that was based on a discovery that fetal DNA is shorter than maternal DNA. Prometheus Laboratories, Inc. ) and the rationale in their application.
Let's personalize your content